Annual Drug Patent Expirations for XOPENEX+HFA Xopenex Hfa is a drug marketed by Lupin and is included in one NDA. It is available from five suppliers. There are two patents…
The post New patent expiration for LUPIN drug XOPENEX HFA appeared first on D…
New patent expiration for LUPIN drug XOPENEX HFA Read Post »
Annual Drug Patent Expirations for EXPAREL Exparel is a drug marketed by Pacira Pharms Inc and is included in one NDA. It is available from one supplier. There are eight…
The post New patent for Pacira Pharms drug EXPAREL appeared first on DrugPatentWa…
This chart shows the companies which have received the most New Patient Population exclusivities in the past five years. New Patient Populations are one of the categories for which the…
The post Pharmaceutical companies with the most ‘New Patient Popul…
Pharmaceutical companies with the most ‘New Patient Population’ drugs Read Post »
Annual Drug Patent Expirations for ZEGALOGUE+%28AUTOINJECTOR%29 Zegalogue (autoinjector) is a drug marketed by Zealand Pharma and is included in one NDA. It is available from two suppliers. There is one…
The post New patent for Zealand Pharma drug ZEGA…
New patent for Zealand Pharma drug ZEGALOGUE (AUTOINJECTOR) Read Post »
STRIVERDI RESPIMAT (olodaterol hydrochloride) Boehringer ingelheim Patent: 7,056,916 Expiration: Dec 7, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Pa…
Drug Patent Expirations for the Week of December 3, 2023 Read Post »
Annual Drug Patent Expirations for ELCYS Elcys is a drug marketed by Exela Pharma and is included in one NDA. It is available from one supplier. There are fourteen patents…
The post New patent for Exela Pharma drug ELCYS appeared first on DrugPatentWat…
Annual Drug Patent Expirations for ZEGALOGUE Zegalogue is a drug marketed by Zealand Pharma and is included in one NDA. It is available from two suppliers. There is one patent…
The post New patent for Zealand Pharma drug ZEGALOGUE appeared first on Dru…
Annual Drug Patent Expirations for STIOLTO+RESPIMAT Stiolto Respimat is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are thirteen…
The post New patent expiration for Boehringer Ingelheim d…
New patent expiration for Boehringer Ingelheim drug STIOLTO RESPIMAT Read Post »
Annual Drug Patent Expirations for STRIVERDI+RESPIMAT Striverdi Respimat is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are thirteen…
The post New patent expiration for Boehringer Ingelhe…
New patent expiration for Boehringer Ingelheim drug STRIVERDI RESPIMAT Read Post »
This chart shows the pharmaceutical companies with the most cream dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most cream dosed drugs…
The post Which pharmaceutical companies have the most cream do…
Which pharmaceutical companies have the most cream dosed drugs? Read Post »
Get new actionable insights and updates from BiotechBlog
